A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis
- 8 May 2001
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 1 (6) , 1189-1198
- https://doi.org/10.1016/s1567-5769(01)00054-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cocaine-Induced Cardiovascular Responses in Rats During Acute Ethanol WithdrawalAlcohol, 1999
- Drugs of Abuse and the BrainProceedings of the Association of American Physicians, 1999
- Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.Experimental and Clinical Psychopharmacology, 1998
- Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategyDrug and Alcohol Dependence, 1997
- Peripheral cocaine-blocking agents: new medications for cocaine dependence1The views and opinions expressed herein are those of the authors and do not necessarily reflect policies of the National Institute on Drug Abuse.1Drug and Alcohol Dependence, 1997
- Efficacy of a therapeutic cocaine vaccine in rodent modelsNature Medicine, 1996
- Antibody-Catalyzed Degradation of CocaineScience, 1993
- Clinical Pharmacology and Toxicology of CocaineBasic & Clinical Pharmacology & Toxicology, 1993
- A potential vaccine for cocaine abuse prophylaxisImmunopharmacology, 1992
- Cocaine-enhanced arrhythmogenesis: neural and nonneural mechanismsCanadian Journal of Physiology and Pharmacology, 1992